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Hematopoiesis: Progenitors and their genetic program
Françoise Dieterlen-Lièvre
Recent advances in our understanding of blood cell
development have included the identification of a
hematopoietic progenitor derived from endothelial cells
and the possibility that the embryonic and fetal
environment can reprogram gene expression in adult
hematopoietic stem cells. 
Address: Institut d’Embryologie Cellulaire et Moléculaire du CNRS et
du Collège de France, 49 bis, Avenue de la Belle Gabrielle, 94736
Nogent-sur-Marne Cedex, France.
E-mail: dieterle@infobiogen.fr
Current Biology 1998, 8:R727–R730
http://biomednet.com/elecref/09609822008R0727
© Current Biology Ltd ISSN 0960-9822
Adult hematopoietic stem cells with multilineage differ-
entiation potential are contained within a self-renewable
pool in vertebrate bone marrow. The mechanisms that are
involved in establishing this pool during embryogenesis
remain elusive, however. Hematopoiesis begins in the
yolk sac blood islands and a region of the aorta in the
embryo proper termed the aorta–gonad–mesonephros
(AGM) in the mouse (reviewed in [1]), and in the allantois
in the avian embryo [2]. These regions have all been
shown to produce hematopoietic progenitors de novo from
mesodermal cells that become committed to the
hematopoietic pathway. These progenitors then colonize a
series of definitive hematopoietic sites, including the fetal
liver, thymus, spleen and bone marrow, which give rise to
sequential generations of blood cells. As the progenitors
differentiate in these various sites, genes specific for each
generation are differentially activated. For example,
globin genes are activated sequentially in erythroid cells.
An epigenetic event is responsible for the selection of the
genetic program that is active in each generation of
hematopoietic cells. It is therefore of interest to identify
the cell stage at which this epigenetic event occurs. 
Interest in the emergence of hematopoietic stem cells in
the embryo has dramatically increased in the last few
years. Due to refinements in cell culture methods and
molecular biology techniques, the potential of a minute
number of cells to undergo differentiation and renewal
can now be determined and the earliest expression of
genes specific for each lineage can be detected. Some
years ago, the extra-embryonic cohort of primitive
hematopoietic progenitors was demonstrated to be short-
lived in the avian model, with evidence that adult
hematopoiesis arises from intra-embryonic stem cells [3].
It is now known that definitive lymphohematopoietic
stem cells — that is, those giving rise to myeloid cells
and T and B lymphocytes — are independently gener-
ated within the embryo proper in mammals as well
(reviewed in [1]).
Two issues have been the focus of recent attention: the
developmental relationship of endothelial cells and
hematopoietic cells; and the mechanism responsible for
the selection of the particular set of hematopoietic genes
expressed at different times of development. A recent
paper from Nishikawa and colleagues [4] presents some
evidence in favor of endothelial cells with lymphohe-
matopoietic potential in the mouse embryo. Another
paper exploring the second issue suggests that definitive
hematopoietic stem cells can be reprogrammed into primi-
tive hematopoietic stem cells when re-introduced into an
appropriate microenvironment [5]. 
Endothelial cells can give rise to lymphohematopoietic cells
Both hematopoietic and endothelial cells are affected fol-
lowing the homozygous deletion of the gene encoding
vascular endothelial growth factor receptor 2 (VEGF-R2)
[6]. In addition, a mutation induced in zebrafish has led to
the identification of the cloche gene, which is required for
the differentiation of the two lineages [7]. A cogent argu-
ment for a common precursor of these two cell types —
the so-called hemangioblast — is also derived from the
experimental fate of cells in the very early avian blastodisc
that express VEGF-R2 [8]. When cultured in a plasma-
based semi-solid medium, these cells (but not those that
lack VEGF-R2 expression) gave rise to hematopoietic
colonies. The addition of VEGF to the medium induced
the appearance of endothelial colonies while decreasing
the number of hematopoietic colonies. When a soluble
form of VEGF-R2 was added to the medium, hematopoi-
etic colonies disappeared altogether. Strikingly, in none of
the culture conditions used were mixed colonies contain-
ing both endothelial and hematopoietic cells ever
observed, thus making direct identification of the heman-
gioblast impossible.
Nishikawa and colleagues [4,9] undertook to document
the surface phenotype of lymphohematopoietic precur-
sors as they appear during mouse development. These
precursors were found to express the cell adhesion mole-
cule VE-cadherin (VE-cad), which has been reported to
be an exclusive marker of endothelial cells. These VE-
cad-expressing (VE-cad+) cells, which represent a small
fraction of the VEGF-R2+ cells, are already organized in a
tubular network, an obvious criterion of endothelial dif-
ferentiation. VE-cad+ cells from embryonic day 8.5 (E8.5)
embryos gave rise to monocytic and granulocytic colonies
in the appropriate culture conditions, while cells from
E9.5 (but not E8.5) embryos or yolk sacs gave rise to B
lymphocytes when cultured on the OP9 stromal cell line
with interleukin-7, or to T lymphocytes when cultured in
thymocyte-depleted thymic lobes. Nishikawa and col-
leagues conclude that the VE-cad+ cells represent lym-
phohematopoietic endothelial cells, because the cells
that are capable of giving rise to all hematopoietic lin-
eages have an endothelial-specific phenotype (Figure 1).
These studies place the common endothelial/hematopoi-
etic progenitor one step earlier on the differentiation
pathway than previously identified by Keller’s group
using CD31+, VEGF-R2+ cells sorted from embryonic
stem cell derived embryonic bodies [10]. Furthermore,
the progenitors identified by Nishikawa and colleagues
[4] have been shown to have lymphoid potential as well
as myeloid potential.
Interestingly, this expression pattern of cell surface markers
on hematopoietic precursors in the embryo — established
from cells which were taken from the mouse embryo, sorted
and cultured in vitro — is in perfect agreement with an in situ
tracking approach used to establish the origin of avian intra-
embryonic hematopoietic cells [11]. The fate of endothelial
cells in the E2 aorta was followed after labeling these
endothelial cells by the uptake of low density lipoproteins or
by the integration of a retroviral vector bearing a marker
gene. The hematopoietic cells, which typically emerge from
the endothelial floor of the aorta at E3, bore the two markers.
Furthermore, the endothelial floor at E2 expressed the
endothelial-specific (or maybe hemangioblast-specific)
antigen VEGF-R2, while at E3 it expressed the pan-leuko-
cyte cell surface antigen CD45. Thus, in both mammalian
and avian embryos, cells which were identified as endothe-
lial cells were shown by different methods of analysis to
switch to a hematopoietic fate. In both cases, the identifica-
tion of intermediate steps in the commitment process will
depend on the availability of molecular or cytological probes
to distinguish between these steps.
Can definitive hematopoietic stem cells be reprogrammed? 
The progenies of primitive, fetal and definitive
hematopoietic stem cells express different sets of lineage-
specific genes, such as globin genes or variable segments
of the T-cell receptor. Albrecht Müller’s group decided to
investigate the mechanism of the genetic switches in suc-
cessive generations of hematopoietic cells (Figure 2) by
injecting adult bone marrow hematopoietic stem cells
(which have the surface antigen phenotype Lin–, c-kit+,
Sca-1+) into mouse blastocysts [5]. Erythroid progeny,
identified as being derived from the injected adult cells by
an array of markers, were found in the hematopoietic
tissues of a significant proportion of recipients, at the
embryonic, fetal, and adult stages of hematopoiesis.
Chimeras were constructed with adult mouse bone
marrow cells transgenic for a human β globin locus, which
contains the embryonic (ε), fetal (γ), and adult (β) globin
genes. The human genes expressed at different embry-
onic stages were then analyzed by the highly sensitive
reverse transcription-based polymerase chain reaction
(RT–PCR) approach to detect the ε, γ, and β globin genes.
In E10.5 yolk sac and AGM, and in E11.5 and E12.5 yolk
sac and fetal liver, the human ε and γ globin transgenes
were transcribed. A weak β globin (adult) signal was
detected in only 2 out of 16 chimeric E12.5 embryos.
Thus, the authors concluded that the embryonic and fetal
environment can reprogram adult hematopoietic stem
cells to express embryonic and fetal genes.
A choice between fates is a usual occurrence in develop-
ment. Thus, the problem has often been considered to be
whether programming is imposed on responsive cells by
the environment — ‘instructivity’ — or whether survival
factors are responsible for the selection of cells able to
thrive in a particular environment — ‘permissivity’.
Müller and colleagues favor the former possibility.
Indeed, developmental choices between possible fates are
known to be influenced by cell–cell contact mediated by
ligand–receptor interactions. In the present experiments,
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Figure 1
Expression of various cell surface markers as
cells undergo commitment to the
hematopoietic pathway in the E8.5–9.5 mouse
embryo [4,9]. In particular, it is not clear
whether lymphohematopoietic endothelial
cells pass through a hemangioblast stage.
Myeloid and lymphoid colonies were obtained
by seeding lymphohematopoietic endothelial
cells in distinct culture conditions.
Intermediate differentiation stages were not
documented by the experiments and are
shown as dashed arrows. Note that the
lymphohematopoietic endothelial cells express
the endothelial-specific markers VE-cad and
CD31. LDL, low density lipoprotein.
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however, the progenitors — sorted on the basis of Sca-1
and c-kit expression — are committed to the hematopoi-
etic pathway and their genetic program is therefore likely
to have already been selected. It is also important to bear
in mind that a fraction of adult erythropoietic cells has
often been demonstrated to express the embryonic or fetal
program. These cells might be selected for in the embry-
onic environment, while the adult hematopoietic stem
cells might not find the survival factors they require. It is
nevertheless remarkable that some hematopoietic stem
cells can survive for four days before the first hematopoi-
etic microenvironment, namely the yolk sac, appears. In
the yolk sac itself, it is likely that the range of available
growth factors is different from that in hematopoietic
organs that are functional at later stages of development,
because primitive progenitors can survive in the absence
of a number of hematopoietic-specific cytokines, such as
kit ligand and erythropoietin.
Hematopoietic development still holds many questions for
the future. While the possibility of reprogramming
hematopoietic stem cells needs confirmation, it has become
very clear that the emergence of hematopoietic stem cells
and hemangioblasts in the embryo are tightly linked. One
interesting problem for the future is to determine how long
hemangioblasts and/or lymphohematopoietic endothelial
cells are functional and whether some of these cells settle
and reside in the bone marrow.
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Figure 2
Tentative schemes of the emergence of
hematopoietic stem cells from various locations
during development. Dashed arrows indicate
hypothetical pathways. The locations and the
stages of development are shown beneath
each schematic pathway. (a) The generation of
primitive progenitors in the yolk sac blood
islands (YS). It has been established in the
avian and mammalian models that the
progenitors giving rise to this generation
differentiate without undergoing self-renewal
[1,12,13]. (b) Several possible pathways for
the emergence of long-term reconstituting
hematopoietic stem cells. In (a,b), it is still
unknown whether the hemangioblast
represents a distinct step. Progenitors with
distinct lineage potentials have been found in
the mouse embryo in the region designated as
the paraaortic splanchnopleura (P-Sp) [12] or
aorta–gonad–mesonephros (AGM) [13] at
successive stages. In the avian embryo,
hematopoietic cells bud into the vascular
lumen from the floor of the aorta and later form
prominent paraaortic foci in the dorsal
mesentery. It seems clear that commitment of
hematopoietic progenitors occurs in this region
over several days. In my opinion, the change in
potential is likely to occur as mesodermal cells
become committed to the hematopoietic
pathway (1), rather than during amplification of
the earliest appearing progenitors (2). In the
experiments by Müller and colleagues [5], the
cells that were back-transplanted into the
blastocyst are the hematopoietic stem cells
(orange) identified by the Sca-1 antigen in the
adult bone marrow. Finally, the hematopoietic
stem cells that colonize the bone marrow may
be derived from the stem cells that appear in
the AGM, but the link has yet to be
substantiated (as shown by the question mark).
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